-
Abstract Number: 0615
Socioeconomic Determinants of Lupus Hospitalization Outcomes: A Review of Current Knowledge and Analysis of the 2016-2019 NRD Database
-
Abstract Number: 0616
Disparities in Health-Related Quality of Life Among Patients with Systemic Lupus Erythematosus
-
Abstract Number: 0617
Hereditary C1q Deficiency Is Associated with Type 1 Interferon-pathway Activation and a High Risk of Central Nervous System Inflammation
-
Abstract Number: 0618
Comparison of Cell Type-Specific Polygenic Risk in Systemic Lupus Erythematosus Patient and Healthy Controls
-
Abstract Number: 0619
Prevalence and Factors Predicting Hemophagocytic Lymphohistiocytosis in Hospitalized Patients with Systemic Lupus Erythematosus
-
Abstract Number: 0620
Clinical Efficacy and Patient-Reported Outcomes in Anti-Ro/Sjögren’s Syndrome–Related Antigen a Antibody–Positive Patients with Active SLE Treated WithDeucravacitinib in the Phase 2 PAISLEY Trial
-
Abstract Number: 0621
Predictive Parameters of Disease-related Damage Accrual in Patients with Systemic Lupus Erythematosus: A Machine Learning Analysis
-
Abstract Number: 0622
Translation, Adaptation and Validation of the Brazilian-Portuguese Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) Version: Partial Results from a Single Centre
-
Abstract Number: 0623
Select Patient Reported Outcome Measure Domains Enhance Immune Mediator Based Indexes That Inform Flare Risk and Disease Activity in Systemic Lupus Erythematosus
-
Abstract Number: 0624
Coexisting Tubulointerstitial Inflammation and Damage Is a Risk Factor for Chronic Kidney Disease in Patients with Lupus Nephritis
-
Abstract Number: 0625
Trends, Outcomes, and Predictors of Mortality in Patients with SLE Hospitalized for Influenza
-
Abstract Number: 0626
Impact of the Lupus Foundation of America Rapid Evaluation of Activity in Lupus (LFA-REAL) Patient Reported Outcome (PRO) in Systemic Lupus Erythematosus Patients from the Almenara Lupus Cohort
-
Abstract Number: 0627
Clinical Conditions Associated with Presence of a High-titer Antinuclear Antibody in Individuals Without Autoimmune Disease
-
Abstract Number: 0628
Genetic Determinants of Childhood Onset Systemic Lupus Erythematosus
-
Abstract Number: 0629
Evaluating the Concordance Between SRI4 and BICLA Using Placebo Data from Randomized Controlled Trials of Patients with Active Systemic Lupus Erythematosus
- « Previous Page
- 1
- …
- 41
- 42
- 43
- 44
- 45
- …
- 181
- Next Page »